Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort - PubMed (original) (raw)
Multicenter Study
doi: 10.1093/ndt/gfu399. Epub 2015 Jan 20.
Affiliations
- PMID: 25609740
- DOI: 10.1093/ndt/gfu399
Multicenter Study
Predictors of renal and patient outcomes in anti-GBM disease: clinicopathologic analysis of a two-centre cohort
Bassam Alchi et al. Nephrol Dial Transplant. 2015 May.
Abstract
Background: Patients with anti-glomerular basement membrane (GBM) disease are at increased risk of morbidity and mortality from renal failure, pulmonary haemorrhage or complications of treatment. One-third also have circulating anti-neutrophil cytoplasmic antibodies (ANCA). The aim of this study was to determine the clinicopathologic predictors of patient and renal outcomes in anti-GBM disease with or without ANCA.
Methods: Retrospective review of 43 patients diagnosed with anti-GBM disease over 20 years in two centres, including nine with dual anti-GBM and ANCA positivity. Renal biopsies from 27 patients were scored for the presence of active and chronic lesions.
Results: Dual-positive patients were almost 20 years older than those with anti-GBM positivity alone (P = 0.003). The overall 1-year patient and renal survivals were 88 and 16%, respectively. Oligoanuria at diagnosis was the strongest predictor of mortality; none of the 16 patients without oligoanuria died. In a Cox regression model excluding oligoanuria, age was the only other independent predictor of survival. Pulmonary haemorrhage and dialysis dependence did not influence mortality. Thirty-five of the forty-three (81%) patients required dialysis at presentation, including all nine dual-positive patients. Of them, only two (5.7%) regained renal function at 1 year. By logistic regression, oligoanuria at diagnosis and percentage of crescents were independent predictors of dialysis independence at 3 months. However, in biopsied patients, the presence of crescents (>75%) added little to the presence of oligoanuria in predicting dialysis independence. Histological activity and chronicity indices did not predict renal outcome. Two of the nine (22%) dual-positive patients relapsed compared with none of the anti-GBM alone patients. Seven patients received kidney transplants without disease recurrence.
Conclusions: Oligoanuria is the strongest predictor of patient and renal survival while percentage of glomerular crescents is the only pathologic parameter associated with poor renal outcome in anti-GBM disease. Kidney biopsy may not be necessary in oligoanuric patients without pulmonary haemorrhage.
Keywords: anti-glomerular basement membrane; anti-neutrophil cytoplasmic antibodies; crescentic glomerulonephritis; oligoanuria; survival.
© The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.
Similar articles
- Clinicopathological characteristics and predictors of poor outcome in anti-glomerular basement membrane disease - a fifteen year single center experience.
Zahir Z, Wani AS, Prasad N, Jain M. Zahir Z, et al. Ren Fail. 2021 Dec;43(1):79-89. doi: 10.1080/0886022X.2020.1854301. Ren Fail. 2021. PMID: 33334228 Free PMC article. - Predicting Outcome in Patients with Anti-GBM Glomerulonephritis.
van Daalen EE, Jennette JC, McAdoo SP, Pusey CD, Alba MA, Poulton CJ, Wolterbeek R, Nguyen TQ, Goldschmeding R, Alchi B, Griffiths M, de Zoysa JR, Vincent B, Bruijn JA, Bajema IM. van Daalen EE, et al. Clin J Am Soc Nephrol. 2018 Jan 6;13(1):63-72. doi: 10.2215/CJN.04290417. Epub 2017 Nov 21. Clin J Am Soc Nephrol. 2018. PMID: 29162595 Free PMC article. - Clinical outcome of patients with coexistent antineutrophil cytoplasmic antibodies and antibodies against glomerular basement membrane.
Lindic J, Vizjak A, Ferluga D, Kovac D, Ales A, Kveder R, Ponikvar R, Bren A. Lindic J, et al. Ther Apher Dial. 2009 Aug;13(4):278-81. doi: 10.1111/j.1744-9987.2009.00724.x. Ther Apher Dial. 2009. PMID: 19695059 - Goodpasture's disease: a report of ten cases and a review of the literature.
Dammacco F, Battaglia S, Gesualdo L, Racanelli V. Dammacco F, et al. Autoimmun Rev. 2013 Sep;12(11):1101-8. doi: 10.1016/j.autrev.2013.06.014. Epub 2013 Jun 24. Autoimmun Rev. 2013. PMID: 23806563 Review. - Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis.
Rutgers A, Slot M, van Paassen P, van Breda Vriesman P, Heeringa P, Tervaert JW. Rutgers A, et al. Am J Kidney Dis. 2005 Aug;46(2):253-62. doi: 10.1053/j.ajkd.2005.05.003. Am J Kidney Dis. 2005. PMID: 16112043 Review.
Cited by
- Anti-GBM Nephritis in an 11-Year-Old Female Child: A Rare Case Report.
Kale S, Patil M, Mane S, Thorbole N, Matnani M. Kale S, et al. Cureus. 2024 Aug 25;16(8):e67736. doi: 10.7759/cureus.67736. eCollection 2024 Aug. Cureus. 2024. PMID: 39318945 Free PMC article. - Effective management of necrotizing crescentic glomerulonephritis using an aggressive combination therapy including avacopan in a patient double-seropositive for anti-GBM antibodies and ANCA: a case report.
Tanaka R, Toishi T, Masaki R, Aihara H, Sakamoto S, Ikeda M, Inoue T, Kawaji A, Matsunami M, Fukuda J, Ohara M, Kuji H, Ichikawa D, Suzuki T. Tanaka R, et al. CEN Case Rep. 2024 Sep 10. doi: 10.1007/s13730-024-00929-4. Online ahead of print. CEN Case Rep. 2024. PMID: 39254789 - Evaluation of the Risk Prediction Models in Predicting Kidney Outcomes in Antiglomerular Basement Membrane Disease.
Kuang H, Zhao YY, Wang JW, Cui Z, Zhao MH, Jia XY. Kuang H, et al. Kidney Int Rep. 2023 Dec 18;9(3):624-634. doi: 10.1016/j.ekir.2023.12.011. eCollection 2024 Mar. Kidney Int Rep. 2023. PMID: 38481502 Free PMC article. - Clinical Profile and Renal Survival of Anti-Glomerular Basement Membrane Disease Patients: A Retrospective Case Series from Northern India.
Kumar A, Gupta S, Jarial KDS, Sangha S, Chauhan A, Sharma V, Sandal R, Sharma D. Kumar A, et al. Glomerular Dis. 2023 Oct 17;3(1):241-247. doi: 10.1159/000534498. eCollection 2023 Jan-Dec. Glomerular Dis. 2023. PMID: 38021463 Free PMC article. - Pulmonary-Renal Syndrome During COVID-19 Pandemic Revealed a Rare Case of Anti-GBM Disease.
Chalkia A, Koutsianas C, Stampolliou E, Giannou P, Gakiopoulou H, Vassilopoulos D, Petras D. Chalkia A, et al. Mediterr J Rheumatol. 2023 Jun 30;34(2):252-256. doi: 10.31138/mjr.34.2.256. eCollection 2023 Jun. Mediterr J Rheumatol. 2023. PMID: 37654641 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources